Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in United States
274 trials · From ClinicalTrials.gov, checked 19 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in United StatesZanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA
- Where
- Houston, Orange
- Age
- 18 years and over
- People
- 300
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT07780968 - Phase 1Taking peoplePhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
- Where
- Boston, Fairfax, Irving, Lubbock, Oklahoma City, Orlando
- Age
- 18 years and over
- People
- 285
- Run by
- Sutro Biopharma, Inc.
See details and how to joinNCT07807345 - Phase 1Taking peopleA Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Where
- Houston, San Antonio, Scottsdale
- Age
- 18 years and over
- People
- 30
- Run by
- SHY Therapeutics
See details and how to joinNCT07705334 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Atlanta, Austin, Canton, Celebration, Charleston, Cincinnati, Dallas, Dayton, Detroit, Fairfax, Greenville, Las Vegas, Los Angeles, Louisville, Margate, Nashville, New York, Orlando, Plantation, Saint Paul, Santa Monica, Spokane, Tamarac, Tucson
- Age
- 18 years and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - Phase 1/2Taking peoplePhase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- Where
- Duarte, Fairfax, Santa Monica
- Age
- 18 years and over
- People
- 164
- Run by
- BigHat Biosciences, Inc.
See details and how to joinNCT07529808 - Phase 1Not yet taking people in United StatesFutibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
- Where
- Chicago, Columbus
- Age
- 18 years and over
- People
- 18
- Run by
- Northwestern University
See details and how to joinNCT07594548 - Phase 3Taking peopleUsing 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
- Where
- Boston, Cerritos, Chicago, Cleveland, Coral Springs, Duarte, Indianapolis, Irvine, Jacksonville, Kettering, Los Angeles, Milwaukee, New York, Philadelphia, Rochester, Stanford, Tampa, Worcester
- Age
- 18 years and over
- People
- 200
- Run by
- SOFIE
See details and how to joinNCT07217704 - Phase 3Taking peopleA Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
- Where
- Albany, Anchorage, Athens, Aurora, Boston, Burnsville, Charleston, Charlottesville, Chicago, Cincinnati, Clifton Park, Columbus, Dallas, Detroit, Duarte, Dyer, Evanston, Fairfax, Grand Rapids, Hinsdale, Jacksonville, Kansas City, Knoxville, La Jolla, Lancaster, Lexington, Los Alamitos, Los Angeles, Louisville, Madison, Marietta, Nashville, Newark, New Hyde Park, New York, Niles, Oklahoma City, Omaha, Orlando, Phoenix, Reno, Richmond, Round Rock, Santa Fe, Santa Monica, Silver Spring, Solvang, St Louis, Summit, Upland, Walnut Creek, Waukee, Webster, Worcester
- Age
- 18 years and over
- People
- 840 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06764875 · EU 2024-512583-57-00 - Phase 3Taking peopleSonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Where
- Anchorage, Atlanta, Birmingham, Blacksburg, Boston, Burlington, Burnsville, Camden, Charleston, Charlotte, Chicago, Cleveland, Columbus, Dallas, Denver, Duarte, Duluth, East Brunswick, Edmonds, Fairfax, Falls Church, Fort Belvoir, Fort Myers, Fountain Valley, Fullerton, Grand Rapids, Hackensack, Hershey, Houston, Indianapolis, Irvine, Issaquah, Jacksonville, Kansas City, La Jolla, Lexington, Lone Tree, Los Alamitos, Louisville, Macon, Memphis, Milwaukee, Minneapolis, Mobile, Nashville, Newark, New Brunswick, New Haven, Newnan, New York, Niles, Olympia, Orange, Orlando, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Rochester, Seattle, Sherman, Silver Spring, Sioux Falls, Springdale, St Louis, St. Petersburg, Summit, The Bronx, Walnut Creek, Washington D.C., Waukee, West Palm Beach, White Plains, Whittier, Wilkes-Barre, Wilmington, Winston-Salem, Worcester, Yankton, York, Zion
- Age
- 18 years and over
- People
- 2,130 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07431281 · EU 2024-519787-40-00 - Phase 2Taking peopleA Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
- Where
- Bullhead City, Canton, Cerritos, Coral Springs, Hialeah, Los Angeles, Plantation, St Louis, Tamarac
- Age
- 18 years and over
- People
- 30
- Run by
- BeOne Medicines
See details and how to joinNCT07554521 - Phase 1Taking peopleA Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Huntersville, Irving
- Age
- 18 years and over
- People
- 130
- Run by
- AbbVie
See details and how to joinNCT07807956 · EU 2026-526097-17-00 - No phaseTaking peopleEvaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
- Where
- Bethesda
- Age
- 2 years to 120 years
- People
- 1,559
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00242723 - Phase 1/2Taking peopleDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Where
- Boston, Denver, Houston, Miami, Nashville, San Antonio
- Age
- 18 years and over
- People
- 330
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT06239194 - Phase 1Taking peopleStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Where
- Aurora, Charleston, Chicago, Cleveland, Denver, Duarte, Durham, Fairfax, Grand Rapids, Greenville, Houston, Nashville, New York, Providence, San Antonio, San Francisco, Sarasota, St Louis
- Age
- 18 years and over
- People
- 325 worldwide
- Run by
- AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00 - Phase 3Taking peopleA Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Bridgeton, Chandler, Chicago, Colorado Springs, Flemington, Florham Park, Hialeah, Hinsdale, Houston, Kansas City, Las Vegas, Lincoln, Los Alamitos, Nashville, Orlando, Salem, Tacoma, Temple, Westbrook
- Age
- 18 years and over
- People
- 351 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT07043400 · EU 2025-522862-58-00 - Phase 2Taking peopleConcurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
- Where
- Lexington
- Age
- 18 years to 99 years
- People
- 35
- Run by
- Mark Bernard
See details and how to joinNCT07770100 - Phase 2Taking peopleA Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
- Where
- Basking Ridge, Boston, Commack, Harrison, Houston, Middletown, Montvale, New York, Philadelphia, Uniondale
- Age
- 18 years and over
- People
- 49
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06123338 - Phase 1Taking peopleOpen Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Where
- Augusta, Birmingham, Boston, Chicago, Detroit, Duarte, East Brunswick, Fairfax, Fort Worth, Houston, Lake Success, Los Angeles, Miami, Mineola, Nashville, New York, Orlando, Portland, San Antonio, San Diego, St Louis, Zion
- Age
- 18 years and over
- People
- 280
- Run by
- SystImmune Inc.
See details and how to joinNCT06293898 - Phase 2/3Taking peopleSymbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Where
- Annapolis, Arlington, Arlington Heights, Atascadero, Aurora, Bensalem, Bethesda, Bloomington, Boulder, Brandywine, Burbank, Centennial, Chesapeake, Chicago, Cincinnati, Colorado Springs, Columbia, Daytona Beach, Denver, Doylestown, Encino, Englewood, Fairfax, Fairfield, Fleming Island, Galesburg, Germantown, Hampton, Horsham, Irving, Lakewood, Langhorne, Largo, Littleton, Lone Tree, Long Island City, Longmont, Manassas, Marina del Rey, Media, Morristown, Newport News, New York, Niles, Norfolk, Ottawa, Palm Beach Gardens, Pekin, Peoria, Peru, Porter Ranch, Pueblo, Reno, Reston, Rockville, San Francisco, San Luis Obispo, Santa Barbara, Santa Monica, Seattle, Sebring, Sellersville, Silver Spring, Summit, Thornton, Virginia Beach, Washington, Wellington, West Palm Beach, Woodbridge, Wynnewood
- Age
- 18 years and over
- People
- 840 worldwide
- Run by
- Pfizer
See details and how to joinNCT07392892 · EU 2025-524717-86-00 - Phase 1/2Taking peopleA Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Where
- Fairfax, Huntersville, New York, San Antonio
- Age
- 18 years and over
- People
- 499
- Run by
- Arvinas Inc.
See details and how to joinNCT07749586 · EU 2026-525614-57-00 - No phaseTaking peopleTumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
- Where
- Columbia
- Age
- 18 years and over
- People
- 320
- Run by
- University of Missouri-Columbia
See details and how to joinNCT03551951 - Phase 2Taking peopleA Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
- Where
- Ann Arbor, Dallas, Durham, Houston, Palo Alto, Portland, Seattle
- Age
- 18 years and over
- People
- 78
- Run by
- VA Office of Research and Development
See details and how to joinNCT05563766 - Phase 2Taking peopleA Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
- Where
- Arlington, Bedford, Dallas, Duarte, Fort Worth, Grapevine, Irvine, Plano, Santa Monica
- Age
- 18 years and over
- People
- 146 worldwide
- Run by
- Toray Industries, Inc
See details and how to joinNCT06038578 - Phase 1/2Taking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- Fairfax, Grand Rapids, Houston, Pittsburgh, San Antonio, St Louis
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043 - Phase 1/2Taking peoplePhase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
- Where
- Houston
- Age
- 18 years and over
- People
- 10
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07509008